JP2011524741A5 - - Google Patents

Download PDF

Info

Publication number
JP2011524741A5
JP2011524741A5 JP2011511785A JP2011511785A JP2011524741A5 JP 2011524741 A5 JP2011524741 A5 JP 2011524741A5 JP 2011511785 A JP2011511785 A JP 2011511785A JP 2011511785 A JP2011511785 A JP 2011511785A JP 2011524741 A5 JP2011524741 A5 JP 2011524741A5
Authority
JP
Japan
Prior art keywords
antibody
partial sequence
subsequence
seq
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011511785A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011524741A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/045322 external-priority patent/WO2009154995A2/en
Publication of JP2011524741A publication Critical patent/JP2011524741A/ja
Publication of JP2011524741A5 publication Critical patent/JP2011524741A5/ja
Withdrawn legal-status Critical Current

Links

JP2011511785A 2008-05-27 2009-05-27 インターロイキン１０受容体（ｉｌ−１０ｒ）抗体及び使用方法 Withdrawn JP2011524741A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5629908P 2008-05-27 2008-05-27
US61/056,299 2008-05-27
PCT/US2009/045322 WO2009154995A2 (en) 2008-05-27 2009-05-27 Interleukin 10 receptor (il-10r) antibodies and methods of use

Publications (2)

Publication Number Publication Date
JP2011524741A JP2011524741A (ja) 2011-09-08
JP2011524741A5 true JP2011524741A5 (https=) 2012-06-28

Family

ID=41434638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511785A Withdrawn JP2011524741A (ja) 2008-05-27 2009-05-27 インターロイキン１０受容体（ｉｌ−１０ｒ）抗体及び使用方法

Country Status (4)

Country Link
US (1) US8420784B2 (https=)
EP (1) EP2293667A4 (https=)
JP (1) JP2011524741A (https=)
WO (1) WO2009154995A2 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2602971T3 (es) 2010-03-02 2017-02-23 Kyowa Hakko Kirin Co., Ltd. Composición de anticuerpo modificado
CN104160272A (zh) * 2011-12-06 2014-11-19 麻省理工学院 利用人源化的小鼠来确定毒性
NZ710695A (en) * 2013-02-06 2020-05-29 Inhibrx Inc Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
US10214592B2 (en) 2014-08-22 2019-02-26 Nitto Boseki Co., Ltd. Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)
GB201512215D0 (en) 2015-07-13 2015-08-19 Lundbeck & Co As H Agents,uses and methods
US20190185559A1 (en) * 2016-09-02 2019-06-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating neoplasias
BR112019005964A2 (pt) 2016-09-27 2019-06-18 Epicentrx, Inc. proteínas de fusão imunomoduladoras
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
US10894833B2 (en) * 2017-07-20 2021-01-19 H. Lundbeck A/S Agents, uses and methods for treatment
JP2020536518A (ja) * 2017-09-27 2020-12-17 エピセントアールエックス，インコーポレイテッド 免疫調節融合タンパク質
WO2020037043A1 (en) * 2018-08-15 2020-02-20 The Regents Of The University Of California Il-10 inhibition for vaccines and immunotherapy
US20220144911A1 (en) * 2019-02-01 2022-05-12 Uab Research Foundation Methods and compositions for il10 signaling antagonism
KR102517872B1 (ko) * 2019-06-12 2023-04-05 (주)아큐레시스바이오 암의 예방 또는 치료용 조성물
WO2022031885A2 (en) 2020-08-05 2022-02-10 Synthekine, Inc. Il10ra binding molecules and methods of use
US12540188B2 (en) 2020-08-05 2026-02-03 Synthekine, Inc. IL10Rα/IL2Rγ synthetic cytokines
US12286482B2 (en) 2020-08-05 2025-04-29 Synthekine, Inc. IL10RB binding molecules and encoding nucleic acids
KR20240114801A (ko) * 2023-01-17 2024-07-25 한양대학교 산학협력단 Il-10 수용체에 특이적으로 결합하는 항체 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2367132A1 (en) 1999-03-24 2000-09-28 Gene M. Shearer Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (gcs)
US7288390B2 (en) 2000-08-07 2007-10-30 Centocor, Inc. Anti-dual integrin antibodies, compositions, methods and uses
UA81743C2 (uk) * 2000-08-07 2008-02-11 Центокор, Инк. МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
CA2462687A1 (en) 2001-10-02 2003-04-17 Mochida Pharmaceutical Co., Ltd. Novel class ii cytokine receptor
GB0302167D0 (en) 2003-01-30 2003-03-05 Leuven K U Res & Dev T cell phenotype
US7651855B2 (en) * 2003-04-17 2010-01-26 The Trustees Of The University Of Pennsylvania Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
HN2004000285A (es) 2003-08-04 2006-04-27 Pfizer Prod Inc ANTICUERPOS DIRIGIDOS A c-MET
DK2270045T3 (en) * 2004-02-06 2015-04-07 Univ Massachusetts ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINES AND APPLICATIONS THEREOF

Similar Documents

Publication Publication Date Title
JP2011524741A5 (https=)
CY1120414T1 (el) Αντισωματα που συνδεονται me οχ40 και οι χρησεις τους
RU2011129204A (ru) Антитела против ангиопоэтина-2 человека
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
JP2015522252A5 (https=)
JP2012507294A5 (https=)
PE20120211A1 (es) Anticuerpos que tienen especificidad por ox40 humana
JP2011515073A5 (https=)
JP2011501945A5 (https=)
PE20120343A1 (es) Anticuerpo anti-cmet que comprende una region bisagra
EA201290173A1 (ru) Антитела против эндоглина
JP2012502649A5 (https=)
PE20131465A1 (es) Moleculas de union a 4-1 bb
JP2009518005A5 (https=)
CO6231009A2 (es) Anticuerpos ox40 antagonistas y su uso en el tratamiento de enfermedades inflamatorias y autoinmunes
JP2017522903A5 (https=)
PE20170687A1 (es) Proteinas de enlace a cd127
RU2012129735A (ru) Антитела к her3 и их применения
CO6331370A2 (es) Anticuerpos contra el receptor de productos finales de glicosilacion avanzada (rage) y usos de los mismos
JP2016515524A5 (https=)
EA200970879A1 (ru) Связывающие белки, включающие антитела, производные антител и фрагменты антител, которые специфически связываются с cd154, и их применения
NO20083793L (no) Antistoffer mot amyloid-beta peptid
EA201170357A1 (ru) Инженерные антитела к il-13: композиции, способы и применение
JP2011157378A5 (https=)
HRP20161298T1 (hr) Novi antagonisti protutijela i njihovi fab fragmenti protiv gpvi i njihova uporaba